Main
Correction to: British Journal of Cancer (2001) 84, 625–929. doi:10.1054/sj.bjc.2001.1975
Unfortunately due to an error Figure 5 was reproduced incorrectly.
The effect of AQ4N and TPZ on the bone marrow toxicity of cDDP. BDF mice were dosed i.p. with AQ4N (100 mg/kg) 30 min or 6 h prior to cDDP (4 or 8 mg/kg). TPZ (25 mg/kg) was administered 2.5 h prior to cDDP (4 or 8 mg/kg). The survival of bone marrow cells was assessed by the spleen colony assay. Results are means±S.E. for six mice.
The correct version is printed below.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1054/bjoc.2001.1975
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Gallagher, R., Hughes, C., Murray, M. et al. Erratum: The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N. Br J Cancer 87, 1339 (2002). https://doi.org/10.1038/sj.bjc.6600561
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600561
